GEN Exclusives

More »

GEN News Highlights

More »
Oct 25, 2007

Enzyme’s Role in Preventing Heart Disease Revealed

  • Virginia Commonwealth University researchers found that cholesteryl ester hydrolase (CEH) may play a role in reducing heart disease. They suggest that the enzyme not only prevents the formation of new plaques but also reduces existing plaques.

    The investigators focused their efforts on macrophage foam cells, which are responsible for storing large amounts of cholesterol that leads to the clogging of arteries by forming plaques. In a previous study, they found that CEH present in the foam cells regulates the amount of cholesterol that can be removed by HDL.

    Using transgenic mice that were fed a high fat and cholesterol-rich diet, the team was able to show that overexpression of the human gene for CEH in macrophage cells reduced the cholesterol content of atherosclerotic lesions from the artery-clogging foam cells and decreased the lesion area. This made the mice significantly less susceptible to heart disease, the team reports.

    The findings appear in the October issue of The Journal of Clinical Investigation (JCI).



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?